Saturday, December 19, 2009

10th Tysabri went well yesterday.  Next Infusion Jan. 15, 2010.

1 comment:

Anonymous said...

What do you think of this?
http://www.ncbi.nlm.nih.gov:80/pmc/articles/PMC2438208/?tool=pmcentrez

"we were restricted by the Institutional Review Board to collect only data essential to the goal of our study"

"the goal of our studies was to test hematopoietic stem/progenitor cell (HSPC) mobilization in humans after a single dose ... with the anti–functional alpha4-integrin antibody natalizumab."